Investing.com - Verona Pharma ADR (NASDAQ: VRNA) reported fourth quarter EPS of $-0.020, $0.03 worse than the analyst estimate of $0.010. Revenue for the quarter came in at $458K versus the consensus estimate of $5M.
Verona Pharma ADR's stock price closed at $22.450. It is up 80.610% in the last 3 months and up 363.840% in the last 12 months.
Verona Pharma ADR saw 4 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Verona Pharma ADR's stock price’s past reactions to earnings here.
According to InvestingPro, Verona Pharma ADR's Financial Health score is "fair performance".
Check out Verona Pharma ADR's recent earnings performance, and Verona Pharma ADR's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar